# US 12,310,984 B1 · Composition and method for reducing risk of hypocalcemia in periparturient ruminant animals > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 12,310,984 B1 - Document ID: US12310984B1 - Status: Granted - Kind: B1 - Application number: 18/830,440 - Filed: 2024-09-10 - Published: 2025-05-22 - Granted: 2025-05-27 - Earliest claimed: 2023-11-21 - Assignees: Protekta Inc. - Applicants: Protekta Inc. - Inventors: Morten Jakobsen; Lasse Jakobsen; Rod Martin; Meghan Connelly; Patrick Hoffman - Web page: https://patentgrep.com/patent/US12310984B1 ## CPC - A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay} - A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration} - A61P 3/02: Nutrients, e.g. vitamins, minerals - A61K 9/0068: {Rumen, e.g. rumen bolus} - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS ## Abstract A method of reducing risk of periparturient hypocalcemia in a periparturient ruminant animal involves: measuring blood phosphorus concentration in the animal; and, administering a composition containing a phosphorus-binding compound and optionally, a pharmacologically acceptable carrier to the animal during at least part of a prepartum period of the animal, the composition having an effective amount of the phosphorus-binding compound to control the blood phosphorus concentration in a range of 1.5-3.5 mg P per dL of blood in the animal. ## Claims ### Claim 1 A method of reducing risk of periparturient hypocalcemia in at least one periparturient ruminant animal, the method comprising the steps of: a) measuring a blood phosphorus (P) concentration in the at least one periparturient ruminant animal; and b) perorally administering to the periparturient ruminant animal during at least part of a prepartum period of the periparturient ruminant animal a composition comprising: i) an aluminum-based phosphorus-binding compound present in an amount sufficient to provide aluminum at a concentration of 0.2-0.75% Alu by weight of the total dry matter in the feed ration consumed by the animal, wherein the phosphorus-binding compound is selected from the group consisting of synthetic zeolites, aluminum sulfate, aluminum chloride, aluminum hydroxide, a hydrate thereof, and any mixture thereof; and ii) a pharmacologically acceptable carrier comprising one or more animal feed components other than the phosphorus-binding compound; wherein the feed composition provides a dietary phosphorus (P) to aluminum (Al) weight ratio in a range of 0.8:1 to 1.1:1 to control blood phosphorus concentration in the periparturient ruminant animal in a range of 2.0-3.0 mg P per dL of blood; wherein the phosphorus-binding compound reduces bioavailability of phosphorus in a digestive system of the periparturient ruminant animal; wherein the periparturient ruminant animal is a dairy cow; and wherein step a) can be performed before or after step b). ### Claim 2 (depends on 1) The method of claim 1, wherein: if the blood phosphorus concentration is below the range, administration rate of the composition of step b) is decreased or the composition is reformulated to decrease the amount of the compound and/or increase the phosphorus to aluminum ratio; and, if the blood phosphorus concentration is above the range, administration rate of the composition of step b) is increased or the composition is reformulated to increase the amount of the compound relative to phosphorus in the composition and/or decrease the phosphorus to aluminum ratio, so that the blood phosphorus concentration is brought into the range. ### Claim 3 (depends on 1) The method of claim 1, wherein the measuring of step a) is done periodically. ### Claim 4 (depends on 1) The method of claim 1, wherein the phosphorus-binding compound of step b) reduces bioavailability of the phosphorus in a digestive system of the periparturient ruminant animal. ### Claim 5 A composition for reducing risk of periparturient hypocalcemia in a periparturient ruminant animal, the composition comprising: a) an aluminum-based phosphorus-binding compound present in an amount sufficient to provide aluminum at a concentration of 0.2-0.75% Alu by weight of the total dry matter in the feed ration consumed by the animal, wherein the phosphorus-binding compound is selected from the group consisting of synthetic zeolites, aluminum sulfate, aluminum chloride, aluminum hydroxide, a hydrate thereof, and any mixture thereof; and b) a pharmacologically acceptable carrier comprising one or more animal feed components other than the phosphorus-binding compound; wherein the feed composition provides a dietary phosphorus (P) to aluminum (Al) weight ratio in a range of 0.8:1 to 1.1:1 to control blood phosphorus concentration in the periparturient ruminant animal in a range of 2.0-3.0 mg P per dL of blood; wherein the phosphorus-binding compound reduces bioavailability of phosphorus in a digestive system of the periparturient ruminant animal; and wherein the periparturient ruminant animal is a dairy cow. ### Claim 6 (depends on 5) The composition of claim 5, wherein the feed composition is suitable for a dairy cow.